Celldex Therapeutics
CLDX
#4576
Rank
HK$13.53 B
Marketcap
HK$204.03
Share price
-0.68%
Change (1 day)
-6.56%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -HK$18.81

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$18.68. In 2022 the company made an earnings per share (EPS) of -HK$18.60 a decrease over its 2021 EPS that were of -HK$12.76.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$18.811.15%
2022-HK$18.6045.73%
2021-HK$12.76-23.36%
2020-HK$16.65-41.05%
2019-HK$28.25-76.95%
2018-HK$122.5645.03%
2017-HK$84.51-42.54%
2016-HK$147.07-3.82%
2015-HK$152.91-0.76%
2014-HK$154.0729.41%
2013-HK$119.06-0%
2012-HK$119.06-9.73%
2011-HK$131.901312.5%
2010-HK$9.34-95.79%
2009-HK$221.60-49.64%
2008-HK$440.04-82.64%
2007-HK$2,535-44.98%
2006-HK$4,6081270.83%
2005-HK$336.1633.33%
2004-HK$252.12-10%
2003-HK$280.13-16.67%
2002-HK$336.16-38.46%
2001-HK$546.26-4.88%
2000-HK$574.27-81.66%
1999-HK$3,130-87.2%
1998-HK$24,447206.39%
1997-HK$7,97913.02%
1996-HK$7,060

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$31.20 67.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$6.61-64.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$94.00 403.33%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$110.11-689.58%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$14.47-177.50%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$27.24-245.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
-HK$4.44-76.25%๐Ÿ‡บ๐Ÿ‡ธ USA